CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
Povidone-Iodine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04410159
NCT04410159Phase 2Completed
CompareCT.gov

A Pilot, Open-Labelled, Randomised Controlled Trial Of Povidone-Iodine Vs Essential Oil And Tap Water Gargling For COVID-19 Patients

Universiti Sains Islam Malaysia·interventional·Posted Jun 1, 2020·Updated Jul 21, 2020

In Brief

A Phase 2 clinical trial evaluating Povidone-Iodine, Essential oils, and 1 other intervention for COVID-19. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the ability of regular gargling to eliminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the throat and nasopharynx. This 4 arms interventional study compares the effect of gargling using povidone-iodine, essential oils- based, tap water with control (no intervention) among Stage 1 coronavirus disease-2019 (COVID-19) patients. Findings from this study will provide new insight into the importance of gargling in the treatment and prevention of COVID-19.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19
CountriesMalaysia
CollaboratorsUniversiti Kebangsaan Malaysia Medical Centre

Timeline

Phase 2CompletedFinished
202120222023202420252026
First PostedJun 1, 2020
Enrollment StartJun 22, 2020
Primary CompletionJun 29, 2020
Study CompletionJul 6, 2020
TodayJul 2, 2026
Enrollment to primary: 7 daysPosted 6.1 years ago

Interventions

Povidone-Iodinedrug

Gargle

Essential oilsdrug

Gargle

Tap waterother

Gargle